Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 2Phase EARLY_PHASE1 1Phase 4 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 3863Neoplasms 2988Prostatic Neoplasms 1754Colorectal Neoplasms 1430Lung Neoplasms 1331Motor Activity 805Head and Neck Neoplasms 686Pancreatic Neoplasms 663Colonic Neoplasms 655Uterine Cervical Neoplasms 653Carcinoma, Non-Small-Cell Lung 631Carcinoma, Hepatocellular 631Rectal Neoplasms 571Stomach Neoplasms 547Brain Neoplasms 484Ovarian Neoplasms 441Anxiety Disorders 420Pain 419Neoplasm Metastasis 385Esophageal Neoplasms 384Polycystic Ovary Syndrome 374Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Urinary Bladder Neoplasms 351Fatigue 340Melanoma 323Multiple Myeloma 322Lymphoma 306Depression 306Endometrial Neoplasms 290Liver Neoplasms 279

Interventions

Propranolol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Interventional × Hemangioblastoma × Clear all
NCT05424016 2023-12-13

PRO-HEB

Assistance Publique - Hôpitaux de Paris

Phase NA Recruiting
85 enrolled

von Hippel-Lindau Disease, Hemangioblastoma

NCT02120040 2023-04-06

PsychoVHL

Assistance Publique Hopitaux De Marseille

Phase NA Completed
42 enrolled

Hemangioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡